Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells $1,971,169.88 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 5,318 shares of the company’s stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total value of $1,971,169.88. Following the transaction, the executive vice president now directly owns 298 shares of the company’s stock, valued at approximately $110,456.68. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Myriam Curet also recently made the following trade(s):

• On Friday, March 1st, Myriam Curet sold 1,605 shares of Intuitive Surgical stock. The stock was sold at an average price of $383.48, for a total value of $615,485.40.
• On Monday, February 12th, Myriam Curet sold 481 shares of Intuitive Surgical stock. The stock was sold at an average price of $386.09, for a total value of $185,709.29.
• On Friday, January 26th, Myriam Curet sold 4,318 shares of Intuitive Surgical stock. The stock was sold at an average price of $370.15, for a total value of $1,598,307.70.

Intuitive Surgical Stock Performance

ISRG opened at $375.33 on Friday. The firm has a market cap of $133.13 billion, a P/E ratio of 67.75, a price-to-earnings-growth ratio of 4.84 and a beta of 1.36. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76. The business’s fifty day moving average is $386.19 and its 200-day moving average is $345.95.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. The company had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. Intuitive Surgical’s quarterly revenue was up 11.5% on a year-over-year basis. During the same period in the prior year, the firm posted $1.00 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Stifel Nicolaus upped their price target on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, April 8th. Wells Fargo & Company upped their price objective on Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a research note on Friday, January 19th. Piper Sandler upped their price objective on Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a research note on Friday, April 19th. Jefferies Financial Group upped their price objective on Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research note on Friday, April 19th. Finally, Citigroup upped their price objective on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Five equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $396.17.

Institutional Trading of Intuitive Surgical

Several large investors have recently modified their holdings of the stock. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA grew its holdings in shares of Intuitive Surgical by 0.3% during the 4th quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 8,899 shares of the medical equipment provider’s stock worth $3,002,000 after purchasing an additional 27 shares in the last quarter. Advance Capital Management Inc. boosted its stake in Intuitive Surgical by 3.8% in the first quarter. Advance Capital Management Inc. now owns 740 shares of the medical equipment provider’s stock valued at $295,000 after buying an additional 27 shares in the last quarter. Sugarloaf Wealth Management LLC boosted its stake in Intuitive Surgical by 5.7% in the first quarter. Sugarloaf Wealth Management LLC now owns 534 shares of the medical equipment provider’s stock valued at $213,000 after buying an additional 29 shares in the last quarter. Sheaff Brock Investment Advisors LLC boosted its stake in Intuitive Surgical by 1.3% in the fourth quarter. Sheaff Brock Investment Advisors LLC now owns 2,226 shares of the medical equipment provider’s stock valued at $751,000 after buying an additional 29 shares in the last quarter. Finally, Liberty Capital Management Inc. boosted its stake in Intuitive Surgical by 3.8% in the fourth quarter. Liberty Capital Management Inc. now owns 815 shares of the medical equipment provider’s stock valued at $275,000 after buying an additional 30 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.